Draft Guidance for Industry: Nucleic Acid Testing to Reduce the Possible Risk of Parvovirus B19 Transmission by Plasma-Derived Products; Availability

Document ID: FDA-2008-D-0379-0001
Document Type: Notice
Agency: Food And Drug Administration
Topics: No Topics associated with this document
Federal Register Number: E8-17431
View Document:

Details Information

Document Subtype:	NAD-Notice of Availability of Data
Received Date:	July 29 2008, at 08:55 AM Eastern Daylight Time
Start-End Page:	44272 - 44273
Page Count:	2
Comment Start Date:	July 30 2008, at 12:00 AM Eastern Standard Time
Comment Due Date:	October 28 2008, at 11:59 PM Eastern Standard Time

Total: 4

CSL Behring - Comment
Posted: 10/03/2008 ID: FDA-2008-D-0379-0009

Comment Period Closed
Oct 28,2008 11:59 PM ET

Talecris Biotherapeutics - Comment
Posted: 10/18/2008 ID: FDA-2008-D-0379-0010

Comment Period Closed
Oct 28,2008 11:59 PM ET

PPTA - Comment
Posted: 10/29/2008 ID: FDA-2008-D-0379-0011

Comment Period Closed
Oct 28,2008 11:59 PM ET

Cangene Corporation - Comment
Posted: 10/29/2008 ID: FDA-2008-D-0379-0012

Comment Period Closed
Oct 28,2008 11:59 PM ET